The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
17β‐Estradiol inhibition of NADPH oxidase expression in human endothelial cells
Abstract
We investigated the hypothesis that the antiatherosclerotic effect of 17β‐estradiol (E 2 ) is due to a shift in the nitric oxide (NO)/superoxide (O 2 - ) balance in the vessel wall, thereby increasing the bio‐availability of NO. In human umbilical vein cultured endothelial cells, E 2 (1–100 nmol/l), but not 17α‐estradiol, caused a time‐ and concentration‐dependent decrease in expression of the NADPH oxidase subunit gp91phox (up to 60% inhibition at both the mRNA and protein level). This effect was prevented by coincuba‐tion with the estrogen receptor antagonists tamoxifen and ICI 182,780 (1 μmol/1 each). Within the same concentration range, E 2 also up‐regulated endothelial nitric oxide synthase expression (~two fold). Moreover, preincubation of the cells with E 2 or a gp91phox antisense oligonucleotide significantly decreased their capacity to generate O 2 - on phorbol ester stimulation (i.e., assembly of the active NADPH oxidase complex). Blockade of NO synthase activity, on the other hand, had no effect on phorbol ester‐stimulated O 2 - formation. In addition, E 2 (100 nmol/l) inhibited the increase in adhesion molecule and chemokine expression in cells exposed to cyclic strain. Cyclic strain enhanced endothelial O 2 - formation, thereby offsetting the inhibitory effect of NO on the expression of these gene products. E 2 thus seems to act as an antioxidant at the genomic level which by improving the NO/O 2 - balance normalizes expression of proatherosclerotic gene products in endothelial cells.—Wagner, A. H., Schroeter, M. R., Hecker, M. 17β‐Estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J. 15, 2121–2130 (2001)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F., & Korach, K. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0370 · Cited by 2,045
Görlach, A., Brandes, R. P., Nguyen, K., Amidi, M., Dehghani, F., & Busse, R. (2000) · Circulation Research · doi:10.1161/01.res.87.1.26 · Cited by 598 · cited 2×
“On the other hand, there is mounting evidence that NADPH oxidase, a major source of ROS, namely O2 (2), in endothelial cells (13, 25), plays a critical role in the development of atherosclerosis (14).”
Background
Cited by
The complex role of estrogens in inflammation
Straub, R. H. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0001 · Cited by 1,950
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Lassègue, B., & Clempus, R. E. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00758.2002 · Cited by 1,032
Gender, sex hormones, and vascular tone
Orshal, J. M., & Khalil, R. A. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00338.2003 · Cited by 650
NADPH Oxidases in Cardiovascular Health and Disease
Cave, A. C., Brewer, A. C., Narayanapanicker, A., Ray, R., Grieve, D. J., Walker, S., & Shah, A. M. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.691 · Cited by 630
Estrogen Modulation of Endothelial Nitric Oxide Synthase
Chambliss, K. L., & Shaul, P. W. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0045 · Cited by 569
Metadata
- Authors
- Wagner, A. H., Schroeter, M. R., & Hecker, M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-10
- Volume
- 15
- Issue
- 12
- Pages
- 2121-2130
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2084983662
- Cited by
- 229
- References
- 2
- FWCI
- 7.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 17β‐Estradiol inhibition of NADPH oxidase expression in human endothelial cells. https://app.cochat.ai/papers/10.1096/fj.01-0123com
- The paper
- Wagner, A. H., Schroeter, M. R., & Hecker, M. (2001). 17β‐Estradiol inhibition of NADPH oxidase expression in human endothelial cells. The FASEB Journal. https://doi.org/10.1096/fj.01-0123com
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.